Human Peripheral Blood Plasma, Hepatitis B Virus

Signal word

Biohazard

Health hazards

For Biosafety Level 1 Handle as a potentially biohazardous material under at least Biosafety Level 1 containment. The donor(s) have been screened for Hepatitis B, human immunodeficiency viruses or other adventitious agents, unless otherwise reported on the Certificate of Analysis. Regardless of results reported on the Certificate of Analysis Universal Precautions according to 29 CFR 1910.1030 should be followed at all times when handling product. For Biosafety Level 2 Handle as a potentially biohazardous material under at least Biosafety Level 2 containment. These human source materials are associated with human disease, hazards include: percutaneous injury, ingestion, mucous membrane exposure (U.S. Government Publication Biosafety in Microbiological and Biomedical Laboratories). The donor(s) have been screened for Hepatitis B, human immunodeficiency viruses or other adventitious agents, unless otherwise reported on the Certificate of Analysis. Regardless of results reported on the Certificate of Analysis Universal Precautions according to 29 CFR 1910.1030 should be followed at all times when manipulating these cell lines. Host Range: Humans Infectious Dose: Unknown Mode of Transmission: HBV is transmitted by percutaneous or mucosal exposure to infected blood or other body fluid. HBV transmission has been observed with numerous forms of human contact such as perinatal/mother to child, sexual, needle sharing, and occupational/health-care-related. Incubation Period: Usually 24-180 days (average 60-90 days).